Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
Bone Marrow Transplantation|November 12, 2014
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent yearsH W Auner, R Szydlo, J Hoek, et al.
Circulation Research|June 26, 2025
Estrogen Enhances SK Channel Activity to Limit Hippocampal Arteriole ConstrictionDanielle A Jeffrey, Abigail N Russell, Hannah R Ferris, et al.
The Analyst|July 13, 2016
The importance of correcting for variable probe-sample interactions in AFM-IR spectroscopy: AFM-IR of dried bacteria on a polyurethane filmDaniel E Barlow, Justin C Biffinger, Allison L Cockrell-Zugell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2016
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationS Genadieva-Stavrik, A Boumendil, P Dreger, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Heterotypic stressors unmask behavioral influences of PMAT deficiency in miceBrady L Weber, Marissa M Nicodemus, Allianna K Hite, et al.
International Journal of Molecular Sciences|November 25, 2023
Heterotypic Stressors Unmask Behavioral Influences of PMAT Deficiency in MiceBrady L Weber, Marissa M Nicodemus, Allianna K Hite, et al.
BMC Gastroenterology|December 17, 2014
Early life environment and natural history of inflammatory bowel diseasesAbra Y Guo, Betsy W Stevens, Robin G Wilson, et al.
Frontiers in Genetics|August 24, 2023
Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten diseaseNadia L Mitchell, Samantha J Murray, Martin P Wellby, et al.
Leukemia & Lymphoma|October 24, 2000
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacyG H Jackson, B Angus, P J Carey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Pageof 30